PHI with Breast cysts
How does this condition affect your private health insurance?
Mammazysten, or breast cysts, are fluid-filled sacs within the breast tissue. They are benign (non-cancerous) and very common, particularly in women between 35 and 50 years old. They can vary in size from microscopic to several centimeters, sometimes feeling like soft grapes or water-filled balloons under the skin. Symptoms may include a palpable lump, tenderness, or pain, especially premenstrually. While often asymptomatic, larger cysts can cause discomfort. Diagnosis typically involves clinical examination, mammography, ultrasound, and sometimes fine-needle aspiration. Although generally harmless, monitoring is sometimes recommended. They are a common component of fibrocystic breast changes and do not typically increase the risk of breast cancer.
PKV Risk Assessment
However, some insurers would likely still cover you with a risk surcharge of around 5%.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Weeks to months; can resolve spontaneously or persist until intervention.
Duration of Illness (Lifetime)
Recurrent or chronic, often associated with hormonal fluctuations over many years.
Cost of Treatment (Initial)
USD 200 - 1500 (diagnostic imaging, consultation, possible aspiration).
Cost of Treatment (Lifetime)
USD 500 - 5000+ (includes monitoring, follow-up visits, potential repeat aspirations over years).
Mortality Rate
Extremely low, as breast cysts are benign and not life-threatening.
Risk of Secondary Damages
Moderate (anxiety, discomfort, need for repeat diagnostic procedures).
Probability of Full Recovery
High (most are benign and resolve or are easily managed without long-term consequences).
Underlying Disease Risk
Low; typically an isolated benign condition, though commonly associated with fibrocystic changes.